Advertisement

Maligne epitheliale Tumoren

  • Wolfram Sterry
  • Eggert Stockfleth
Chapter
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Maligne Tumoren der Haut sind die häufigste Krebsart des Menschen. Basalzellkarzinome werden in einem anderen Kapitel abgehandelt (Kap. „Basalzellkarzinom“), während die weiteren epithelialen malignen Tumoren hier betrachtet werden. Die Ursachen von Hautkrebs sind vielfältig und umfassen genetische Faktoren, wie beispielsweise eine herabgesetzte DNA-Reparaturkapazität, exogene kanzerogene Faktoren (überwiegend UV-Bestrahlung), aber auch verschiedene humane Papillomviren (HPV), chemische Karzinogene, ionisierende Strahlen und Immunsuppression. Individuelle Faktoren, wie etwa Hautfarbe, Dicke des Stratum corneum, Immunstatus oder chronisch entzündliche Erkrankungen der Haut, können weitere Risikofaktoren sein.

Literatur

Allgemeine Literatur

  1. Bernardi MP, Ngan SY, Michael M et al (2015) Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention. Lancet Oncol  https://doi.org/10.1016/S1470-2045(15)00292-2
  2. Ridky TW (2007) Nonmelanoma skin cancer. J Am Acad Dermatol 57:484–501CrossRefPubMedGoogle Scholar
  3. Stockfleth, E, Rosen T, Schumaak S (Hrsg) (2010) Managing skin cancer. Springer Berlin S. 226Google Scholar
  4. Tuttleton Arron S, Jennings L, Nindl I et al (2011) Viral oncogenesis and its role in nonmelanoma skin cancer. Br J Dermatol 164:1201–1213CrossRefPubMedGoogle Scholar

Aktinische Keratosen

  1. Feldman SR, Fleischer AB Jr (2011) Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications. Cutis 87:201–207PubMedGoogle Scholar
  2. Heaphy MR Jr, Ackerman AB (2000) The nature of solar keratosis: a critical review in historical perspective. J Am Acad Dermatol 43:138–150CrossRefPubMedGoogle Scholar
  3. Martin GM, Stockfleth E (2012) Diclofenac sodium 3 % gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety. J Drugs Dermatol 11:600–608PubMedGoogle Scholar
  4. Stockfleth E, Ferandiz C, Grob JJ et al (2008) Development of a treatment algorithm for actinic keratoses; A European Consensus. Eur J Dermatol 18:651–659PubMedGoogle Scholar
  5. Stockfleth E, Terhorst D, Braathen L et al (2011) on behalf of the European Dermatology Forum: Guideline for the management of actinic keratoses. www.euroderm.org
  6. Werner RN, Stockfleth E, Connoly SM et al (2015) Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis – International League of Dermatological Societies in cooperation with the European. Dermatology Forum – Short version, JEADV 29:2069–2079PubMedGoogle Scholar

Andere Carcinomata in situ

  1. Arlette JP (2003) Treatment of Bowen’s disease and erythroplasia of Queyrat. Br J Dermatol 149:43–49CrossRefPubMedGoogle Scholar
  2. Cox NH, Eedy DJ, Morton CA (2007) Guidelines for management of Bowen’s disease: 2006 update. Br J Dermatol 156:11–21CrossRefPubMedGoogle Scholar
  3. Schwartz RA (1996) Premalignant keratinocytic neoplasms. J Am Acad Dermatol 35:223–242CrossRefPubMedGoogle Scholar

Verruköses Karzinom

  1. Schwartz RA (1995) Verrucous carcinoma of the skin and mucosa. J Am Acad Dermatol 32:1–21CrossRefPubMedGoogle Scholar

Keratoakanthom

  1. Annest NM, VanBeek MJ, Arpey CJ et al (2007) Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature. J Am Acad Dermatol 56:989–993CrossRefPubMedGoogle Scholar
  2. D’Alessandro M, Coats SE, Morley SM et al (2007) Multiple self-healing squamous epithelioma in different ethnic groups: More than a founder mutation disorder? J Invest Dermatol 127:2336–2344CrossRefPubMedGoogle Scholar
  3. Esser AC, Abril A, Fayne S, Doyle JA (2004) Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab. J Am Acad Dermatol 50(5 Suppl):S75–S77CrossRefPubMedGoogle Scholar
  4. Kong HH, Cowen EW, Azad NS et al (2007) Keratoacanthomas associated with sorafenib therapy. J Am Acad Dermatol 56:171–172CrossRefPubMedPubMedCentralGoogle Scholar
  5. Kwiek B, Schwartz RA, Keratoacanthoma KA (2016) An update and review. J Am Acad Dermatol 74:1220–1233CrossRefPubMedGoogle Scholar
  6. Schwartz RA (1994) Keratoacanthoma. J Am Acad Dermatol 30:1–22CrossRefPubMedGoogle Scholar

Spinozelluläres Karzinom

  1. Alam M, Ratner D (2001) Cutaneous squamous-cell carcinoma. N Engl J Med 344:975–983CrossRefPubMedGoogle Scholar
  2. Brantsch KD, Meisner C, Schonfisch B et al (2008) Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncology 9:713–720CrossRefPubMedGoogle Scholar
  3. Breuninger H, Bootz F, Hauschild A et al (2008) Kurzleitlinie – Plattenepitelkarzinom der Haut. J Dtsch Dermatol Ges 6:S5–S8CrossRefPubMedGoogle Scholar
  4. Cassarino DS, Derienzo DP, Barr RJ (2006a) Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part I. J Cutan Pathol 33:191–206PubMedGoogle Scholar
  5. Cassarino DS, Derienzo DP, Barr RJ (2006b) Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part II. J Cutan Pathol 33:261–279CrossRefPubMedGoogle Scholar
  6. Combemale P, Bousquet M, Kanitakis J et al (2007) Malignant transformation of leg ulcers: A retrospective study of 85 cases. J Eur Acad Dermatol Venereol 21:935–941CrossRefPubMedGoogle Scholar
  7. Farasat S, SS Y, Neel VA et al (2011) A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 64:1051–1059CrossRefPubMedPubMedCentralGoogle Scholar
  8. Kim M, Murrell DF (2015) Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa. Eur J Dermatol 25(Suppl 1):30–32PubMedGoogle Scholar
  9. Lambert SR, Mladkova N, Gulati A et al (2014) Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling. Br J Cancer 110:520–529CrossRefPubMedGoogle Scholar
  10. Micali G, Nasca MR, Innocenzi D, Schwartz RA (2006) Penile cancer. J Am Acad Dermatol 54:369–391CrossRefPubMedGoogle Scholar
  11. Motley R, Kersey P, Lawrence C (2002) Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 146:18–25CrossRefPubMedGoogle Scholar
  12. Nissinen L, Farshchian M, Riihilä P, Kähäri VM (2016) New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma. Cell Tissue Res 365:691–702CrossRefPubMedGoogle Scholar

Tumoren bei immunosupprimierten Patienten

  1. Lonsdorf AS, Becker MR, Stockfleth E et al (2010) Primary and secondary prevention of skin cancer in organ transplant recipients. Hautarzt 6:195–206CrossRefGoogle Scholar
  2. Ulrich C, Kanitakis J, Stockfleth E, Euvrard S (2008) Skin cancer in organ transplant recipients – where do we stand today? Am J Transplant 8:2192–2198CrossRefPubMedGoogle Scholar
  3. Zwald FO, Brown M (2011a) Skin cancer in solid organ transplant recipients: advances in therapy and management: Part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 65:253–261CrossRefGoogle Scholar
  4. Zwald FO, Brown M (2011b) Skin cancer in solid organ transplant recipients: advances in therapy and management: Part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 65:263–279CrossRefGoogle Scholar

Kutane Metastasen

  1. Fernandez-Flores A (2010) Cutaneous metastases: a study of 78 biopsies from 69 patients. Am J Dermatopathol 2:222–239Google Scholar
  2. Lookingbill DP, Spangler N, Helm KF (1993) Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol 29:228–236CrossRefPubMedGoogle Scholar
  3. Schwartz RA (1995) Histopathologic aspects of cutaneous metastatic disease. J Am Acad Dermatol 33:649–657CrossRefPubMedGoogle Scholar

Erstbeschreiber

  1. Ackerman LV (1948) Verrucous carcinoma of the oral cavity. Surgery 23:670–678PubMedGoogle Scholar
  2. Aird I, Johnson HD, Lennox B et al (1954) Epithelioma cuniculatum. A variety of squamous carcinoma peculiar to the foot. Br J Surg 42:245–250CrossRefPubMedGoogle Scholar
  3. Bowen JT (1912) Precancerous dermatoses: a study of two cases of chronic atypical epithelial proliferation. J Cutan Dis 30:241–255Google Scholar
  4. Buschke A, Löwenstein L (1925) Über carcinomähnliche Condylomata acuminata des Penis. Berlin. Klin Wochenschr 4:1726–1728CrossRefGoogle Scholar
  5. Diaz-Cascajo C, Borghi S, Weyers W et al (2004) Follicular squamous cell carcinoma of the skin: a poorly recognized neoplasm arising from the wall of hair follicles. J Cutan Pathol 31:19–25CrossRefPubMedGoogle Scholar
  6. Dubreuilh W (1896) Des hyperkératoses circonscrites. Ann Dermatol Vénérol 27:1158–1204Google Scholar
  7. Dupont A (1930) Kyste sébacé atypique. Bull Soc Belge Dermatol:177–179Google Scholar
  8. Ferguson-Smith J (1934) A case of multiple primary squamous-cell carcinomata of the skin in a young man with spontaneous healing. Br J Dermatol 46:267–272CrossRefGoogle Scholar
  9. Freudenthal W (1926) Verruca senilis und Keratoma senile. Arch Dermatol Syph 152:505–528CrossRefGoogle Scholar
  10. Gottron HA (1932) Ausgedehnte, ziemlich symmetrisch angeordnete Papillomatosis cutis. Zentralbl Haut Geschlechtskr 40:445Google Scholar
  11. Grzybowski M (1950) A case of peculiar generalized epithelial tumors of the skin. Br J Dermatol 62:310–313CrossRefGoogle Scholar
  12. Hutchinson J (1889) The crateriform ulcer of the face, a form of acute epithelial cancer. Trans Pathol Soc London 40:275–281Google Scholar
  13. Marjolin JN (1828) Ulcère. Dictionnaire de Médecine 21:31–50Google Scholar
  14. Mayo WJ (1928) Metastases in cancer. Proc Staff Meet Mayo Clinic 3:327. Dr. Mayo war der Chef von Sister Mary Joseph, und hat deren Beobachtung publiziertGoogle Scholar
  15. Miedzinski F, Kosakiewicz J (1962) Das Keratoakanthoma centrifugum – eine besondere Varietät des Keratoakanthoms. Hautarzt 13:348–352Google Scholar
  16. Neumann I (1869) Über die senilen Veränderungen der Haut. Sitzungsbericht der Akademie Wissenschaften Wien Mathematisch-naturwissenschaftliche KlasseGoogle Scholar
  17. Pott P (1775) Chirurgical observations relative to the cataract, the polypus of the nose, the cancer of the scrotum, the different kinds of ruptures and the martification of the toes and feet. Hawes, Clarke and Collins, London, S 63–68Google Scholar
  18. Queyrat M (1911) Érythroplasie du gland (1). (Planche I) Ann Dermatol Syph 5ème série. Tome II. Bull Soc Fr Dermatol Syph 22:378–382Google Scholar
  19. Rock JA, Fischer ER (1960) Florid papillomatosis of the oral cavity and larynx. Arch Otolaryngol 72:480–493CrossRefGoogle Scholar
  20. Witten VH, Zak FG (1952) Multiple primary, self-healing prickle-cell epithelioma of the skin. Cancer 5:539–550CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Klinik für Dermatologie, Venerologie und AllergologieCampus Charité MitteBerlinDeutschland
  2. 2.St. Josef-HospitalUniversitätshautklinik BochumBochumDeutschland

Section editors and affiliations

  • Roland Kaufmann
    • 1
  1. 1.Direktor der Klinik für Dermatologie, Venerologie und AllergologieKlinikum der J.W.Goethe-UniversitätFrankfurt am MainDeutschland

Personalised recommendations